Cargando…
Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
Quinacrine has been identified as a potent DR5-inducing agent that sensitizes cancer cells to TRAIL-induced apoptosis. In the current study, we found that quinacrine increased DR5 mRNA levels significantly in ovarian cancer cell lines regardless of p53 status. Further study showed the half-life of D...
Autores principales: | Liang, Rui, Yao, Yuanfei, Wang, Guangyu, Yue, Er, Yang, Guangchao, Qi, Xiuying, Wang, Yang, Zhao, Ling, Zheng, Tongsen, Zhang, Yanqiao, Wenge Wang, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379129/ https://www.ncbi.nlm.nih.gov/pubmed/32766144 http://dx.doi.org/10.3389/fonc.2020.01118 |
Ejemplares similares
-
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
por: Yue, Er, et al.
Publicado: (2021) -
Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
por: Eriksson, A, et al.
Publicado: (2015) -
Parenteral Quinacrine in Malarial Fevers
por: Basumullick, K. L., et al.
Publicado: (1947) -
Treatment of Oriental Sore with Quinacrine
por: Sachdeva, Y. V.
Publicado: (1943) -
Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)